Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Clinical Epigenetics International Meeting
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
[Information processing speed and influential factors in multiple sclerosis].
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Multiple sclerosis review.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Mechanism of action for leflunomide in rheumatoid arthritis.
FDA product review for daclizumab
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
Clinical proteomics of enervated neurons.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
Pages
« first
‹ previous
…
81
82
83
84
85
86
87
88
89
…
next ›
last »